Chrysalis Advisory provided Project Advisory services to support the startup and development of the ECI Clinical Trials Project which aims to improve access to clinical trials for patients by establishing an interactive network of trial sites.
Nick Northcott worked with CSI to support the ideation and development of the ambitious Amplify Social Impact project. In Australia, we spend $500 billion on social purpose programs and initiatives, yet often, we don’t know if they are effective. Its purpose is to reveal the actions and strategies to address complex social problems and improve and transform lives.
A start-up building next generation medical devices utilising novel material science, user driven design, and advanced manufacturing, Chrysalis has provided startup and commercialisation advisory services. Our first product innovation, aka ‘Project Geldom’, is bringing Industry 4.0 to the condom industry, a growing $8B business producing 27B condoms annually. Eudaemon is replacing legacy latex with tough hydrogels to create better feeling, safer and more-cost effective condoms in order to revolutionize safe sex, reduce STIs and promote family planning globally.